XII. Discussion Regarding Costs Associated with Treatment of Non-Negligent 
Research-Related Injury/(Continued) 59 
XIII. Amendment to the Points to Consider Regarding Safety of Delivery/ 
Expression Systems and Report of Murine Replication-Competent 
Retrovirus (RCR) Assays (Continued) 62 
XIV. Discussion Regarding Proposed Review of European Human Gene Therapy 
Protocol (Continued) 69 
XV. Discussion Regarding Compassionate Plea Exemptions to RAC 
Review/Dr. Walters and Mr. Barton 71 
XVI. Future Meeting Date of the Recombinant DNA Advisory Committee 77 
XVII. Adjournment 77 
Attachment - Roster 
[530] 
Recombinant DNA Research, Volume 16 
